Invetx
AcquiredBiotech built for pets
Boston, United States · Founded 2018
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- invetx.com
- Last Round
- Series BMay 2022
- Rounds
- 3
About
Founded in 2018 and headquartered in Boston, Massachusetts, Invetx is a biopharmaceutical company building the world's premier animal health biotechnology platform. By leveraging validated protein-engineering technologies from human biopharma and optimizing them for veterinary application, Invetx develops novel, differentiated protein-based therapeutics to treat chronic and serious diseases in companion animals including dogs and cats. The company partners with leading biotech firms to generate best-in-class antibodies across a wide range of targets, aiming to transform standards of care in veterinary medicine. Invetx was acquired by Dechra Pharmaceuticals.
Summary
Invetx is a Biotech company based in Boston, United States, founded in 2018. Its most recent funding was a Series B round in May 2022. Investors include F-Prime Capital, Novo Holdings and GV.
Tech & App Stack
7 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
May 2022
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...